IL33 and atherosclerosis: Preliminary results showed that such an inhibitory action of IL-33 extended to other key atherosclerosis-associated genes: lipoprotein lipase, a key enzyme involved in the control of lipoprotein metabolism26; the adhesion protein ICAM-1, and the chemokines MCP-1, interferon gamma-induced protein-10 and macrophage inflammatory protein-1β in THP-1 macrophages (data not shown).